Form 4 Tracker
Kura Oncology, Inc.
KURA

13 insider filings · Latest: Jun 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 21, 2026May 22 4:05 PMBrian T. PowlChief Commercial Officer
Sale
10,000$11.00$110.0K173,614(D)

View →

May 19, 2026May 20 4:05 PMBrian T. PowlChief Commercial Officer
Sale
339$9.21$3.1K183,614(D)

View →

May 19, 2026May 20 4:05 PMKathleen FordChief Operating Officer
Sale
2,257$9.08$20.5K153,560(D)

View →

May 18, 2026May 20 4:05 PMTeresa Brophy BairChief Legal Officer
Sale
2,256$9.38$21.2K226,931(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 4, 2026Jun 4 6:30 PMDiane L. ParksDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 6:30 PMMichael VasconcellesDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 6:30 PMHasnain FaheemDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 6:30 PMHelen Louise CollinsDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 6:30 PMCarol SchaferDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 6:30 PMMary T SzelaDirector
Grant/Award
35,000$8.7735,000(D)

View →

Jun 4, 2026Jun 4 6:30 PMThomas MalleyDirector
Grant/Award
35,000$8.7735,000(D)

View →

Mar 23, 2026Mar 25 9:00 AMTroy Edward WilsonDirector, President and CEO
Option Exercise
6,103$6.150(D)

View →

Mar 18, 2026Mar 20 9:00 AMThomas MalleyDirector
Option Exercise
10,000$3.120(D)

View →